Jung M Y, Hof P R, Schmauss C
Department of Psychiatry/Neuroscience, Columbia University/New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA.
Neuroscience. 2000;97(3):495-504. doi: 10.1016/s0306-4522(00)00027-0.
The present study used mice deficient for dopamine D(2) and D(3) receptors to test whether the expression of these two members of the D(2) class of receptors is essential for the normal expression of three markers that characterize the neurochemical differentiation of the striatum: the calcium-binding protein calbindin, tyrosine hydroxylase and acetylcholinesterase. Results from these experiments revealed that the expression of striatal tyrosine hydroxylase (the rate-limiting enzyme of dopamine synthesis) and acetylcholinesterase is unaffected even by the combined knockout of D(2) and D(3) receptors. However, D(2) and D(3) receptor knockouts differently affect the striatal expression of calbindin-D(28k) immunoreactivity. Prominent changes in the cellular distribution of calbindin are detected in striatal neurons of D(2) mutant mice. Whereas calbindin immunolabeling of wild-type neurons is prominent in the nuclei and the cytoplasm of medium spiny neurons, in D(2) mutant mice, calbindin immunoreactivity is concentrated exclusively in the cytoplasmic rim of these neurons. Such changes in the cellular distribution of calbindin expression are not detected in mice lacking D(3) receptors. In these mutants, however, a lesser density of calbindin-immunoreactive neuropil is detected in the ventral portions of the striatum, i.e. in regions in which D(3) receptors are thought to be expressed at highest levels. Mice lacking both D(2) and D(3) receptors show both phenotypes. The altered cellular distribution of calbindin in D(2) mutants is likely to have functional consequences for some of the Ca(2+)-mediated cellular functions. The topography of the decreased density of striatal calbindin immunorectivity in D(3) mutants suggests a role for D(3) receptors in supporting the expression of striatal calbindin. The observation that mice lacking both D(2) and D(3) receptors show a combination of the D(2) and D(3) mutant phenotypes indicates that each of the different phenotypes detected in the single mutants is indeed related to the lack of the two different D(2)-like receptor subtypes.
本研究使用多巴胺D(2)和D(3)受体缺陷型小鼠,以测试D(2)类受体的这两个成员的表达对于表征纹状体神经化学分化的三个标志物的正常表达是否必不可少:钙结合蛋白钙视网膜蛋白、酪氨酸羟化酶和乙酰胆碱酯酶。这些实验结果表明,即使D(2)和D(3)受体联合敲除,纹状体酪氨酸羟化酶(多巴胺合成的限速酶)和乙酰胆碱酯酶的表达也不受影响。然而,D(2)和D(3)受体敲除对钙视网膜蛋白-D(28k)免疫反应性的纹状体表达有不同影响。在D(2)突变小鼠的纹状体神经元中检测到钙视网膜蛋白细胞分布的显著变化。野生型神经元的钙视网膜蛋白免疫标记在中等棘状神经元的细胞核和细胞质中很突出,而在D(2)突变小鼠中,钙视网膜蛋白免疫反应性仅集中在这些神经元的细胞质边缘。在缺乏D(3)受体的小鼠中未检测到钙视网膜蛋白表达细胞分布的此类变化。然而,在这些突变体中,在纹状体腹侧部分,即被认为D(3)受体表达水平最高的区域,检测到钙视网膜蛋白免疫反应性神经纤维的密度较低。同时缺乏D(2)和D(3)受体的小鼠表现出两种表型。D(2)突变体中钙视网膜蛋白细胞分布的改变可能对一些Ca(2+)介导的细胞功能产生功能影响。D(3)突变体中纹状体钙视网膜蛋白免疫反应性密度降低的拓扑结构表明D(3)受体在支持纹状体钙视网膜蛋白表达方面发挥作用。同时缺乏D(2)和D(3)受体的小鼠表现出D(2)和D(3)突变体表型的组合这一观察结果表明,在单个突变体中检测到的每种不同表型确实与缺乏两种不同的D(2)样受体亚型有关。